RGV Endocrine Center has several ongoing clinical trials which are recruiting for patients who suffer from obesity.
- GLP-1* Use in Obese Patients
- Genetic Obesity in Obese Patients (EMANATE)
If you are interested in participating please Contact Us or call our research department at (956)278-0366.
*GLP-1's are a drug class of once weekly injections indicated for treating diabetes and obesity such as Ozempic, Mounjaro and Wegovy.